First-trimester fasting glycemia as a predictor of gestational diabetes (GDM) and adverse pregnancy outcomes
- PMID: 31984438
- DOI: 10.1007/s00592-019-01474-8
First-trimester fasting glycemia as a predictor of gestational diabetes (GDM) and adverse pregnancy outcomes
Abstract
Aims: Studies to prevent gestational diabetes (GDM) have shown the best results when lifestyle measures have been applied early in pregnancy. We aimed to investigate whether first-trimester fasting plasma glucose (FPG) could predict GDM risk and adverse pregnancy outcomes.
Methods: A retrospective analysis of prospectively collected data from singleton pregnancies who were attended at our hospital between 2008 and 2018 (n = 27,198) was performed. We included patients with a recorded first-trimester FPG and complete pregnancy data (n = 6845). Patients under 18, with pregestational diabetes or reproductive techniques, were excluded. First-trimester FPG was evaluated as a continuous variable and divided into quartiles. GDM was diagnosed by NDDG criteria. The relationship between first- and second-trimester glucose > 92 mg/dL was also investigated. The relationship between FPG and pregnancy outcomes was assessed in 6150 patients who did not have GDM.
Results: Maternal age was 34.2 ± 3.9 years, BMI 23.1 ± 3.7 kg/m2 and mean FPG 83.0 ± 7.3 mg/dL. Glucose quartiles were: ≤ 78, 79-83, 84-87 and ≥ 88 mg/dL. First-trimester FPG predicted the risk of GDM (7%, 8%, 10.2% and 16% in each quartile, p < 0.001) and the risk of second-trimester glucose > 92 mg/dL (2.6%, 3.8%, 6.3% and 11.4% in each quartile, p < 0.001). FPG was significantly associated with LGA (8.2%, 9.3%, 10% and 11.7% in each quartile, p = 0.011) but not with other obstetrical outcomes. In a multivariate analysis including age, BMI, tobacco use, number of pregnancies and weight gained during pregnancy, first-trimester FPG was an independent predictor of LGA.
Conclusions: First-trimester FPG is an early marker of GDM and LGA.
Keywords: First-trimester glycemia; Gestational diabetes prediction; Glycemia; Pregnancy outcomes.
References
-
- Landon MB, Carpenter MW, Wapner RJ et al (2009) A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 361(14):1339–1348 - DOI
-
- Crowther CA, McPhee AJ (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352(24):2477–2486 - DOI
-
- Albareda M, Caballero A, Badell G et al (2003) Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care 26:1199–1205. https://doi.org/10.2337/diacare.26.4.1199 - DOI - PubMed
-
- Duran A, Sáenz S, Torrejón MJ et al (2014) Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: the St. Carlos gestational diabetes study. Diabetes Care 37:2442–2450. https://doi.org/10.2337/dc14-0179 - DOI - PubMed
-
- Corcoy R, Lumbreras B, Luis Bartha J, Ricart W (2010) Nuevos criterios diagnósticos de diabetes mellitus gestacional a partir del estudio HAPO. ¿Son válidos en nuestro medio? Gac Sanit 24:361–363. https://doi.org/10.1016/j.gaceta.2010.03.007 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
